Compound Detail

CHEMBL4864991

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

C[C@H]1[C@@H](OCC(O)CO[C@H]2O[C@@H]3O[C@]4(C)CC[C@H]5[C@H](C)CC[C@@H]([C@H]2C)[C@@]35OO4)O[C@@H]2O[C@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL4864991
Phase	Preclinical
Structure Type	MOL
InChI Key	OWMLCUDUBMKZIQ-YRMPQYJJSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

624.8

MW (Da)

4.80

ALogP

HBA

HBD

112.5

PSA (Å²)

0.41

QED

Ro5 Violations

Rot. Bonds

First in Class Prodrug

IC50 4 meas. best 6.11

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
786-0 CHEMBL613102	IC50	6.11	6.11	770.0	1
HeLa CHEMBL399	IC50	5.68	5.68	2070.0	1
PC-3 CHEMBL390	IC50	5.51	5.51	3120.0	1
Jurkat CHEMBL397	IC50	5.44	5.44	3640.0	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
786-0	IC50	=	770.0	nM	6.11	Anticancer activity against human 786-0 cells assessed as inhibition of cell pro...	34399390
HeLa	IC50	=	2070.0	nM	5.68	Anticancer activity against human HeLa cells assessed as inhibition of cell prol...	34399390
PC-3	IC50	=	3120.0	nM	5.51	Anticancer activity against human PC-3 cells assessed as inhibition of cell prol...	34399390
Jurkat	IC50	=	3640.0	nM	5.44	Anticancer activity against human Jurkat cells assessed as inhibition of cell pr...	34399390

PubMed	DOI	Target Context	# Activities
34399390	10.1016/j.ejmech.2021.113754	HeLa	1
34399390	10.1016/j.ejmech.2021.113754	PC-3	1
34399390	10.1016/j.ejmech.2021.113754	Jurkat	1
34399390	10.1016/j.ejmech.2021.113754	786-0	1
34399390	10.1016/j.ejmech.2021.113754	MCF7	1

Data from ChEMBL 36 via Core Engine